These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3818522)

  • 1. Comparative evaluation of lung functional changes with atropine methonitrate and salbutamol in plain and sustained forms.
    Patel MH; Kolhatkar VP; Mahashur AA; Kamat SR
    J Assoc Physicians India; 1986 Oct; 34(10):717-8. PubMed ID: 3818522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value and limitations of salbutamol in the treatment of the obstructive syndrome. Comparative study with a synthetic atropine-like agent].
    Uffholtz H; Sadoul P; Lempereur L; Sentissi M
    Minerva Med; 1976 Mar; 67(15):917-21. PubMed ID: 131259
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with delayed-action salbutamol].
    Zanotelli F
    Minerva Med; 1976 Mar; 67(16):1019-22. PubMed ID: 1264374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
    Fiora L
    Minerva Med; 1976 Apr; 67(17):1165-75. PubMed ID: 1264395
    [No Abstract]   [Full Text] [Related]  

  • 6. Atropine methonitrate and salbutamol in chronic airways obstruction: peak effect and duration of action.
    Starke ID; Parker RA; Turner-Warwick M
    Respiration; 1982; 43(1):51-6. PubMed ID: 7089390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type].
    Melillo G; D'Amato G; Cocco G
    Minerva Med; 1976 Mar; 67(15):964-8. PubMed ID: 1264368
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction.
    Pierce RJ; Allen CJ; Campbell AH
    Thorax; 1979 Feb; 34(1):45-50. PubMed ID: 375461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Respiratory, cardiological and metabolic functional studies of the effects of salbutamol in bronchopathic patients of various ages].
    Babolini G; Gemelli M; Capone M; Coglitore G; Ministeri S; Girbino G; Pinizzotto G; Barberio G
    Minerva Med; 1976 Mar; 67(16):1058-66. PubMed ID: 1264381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and physiopathological study of obstructive bronchopneumopathies treated with salbutamol].
    Giuliano V; Martelli GC; Verrua D
    Minerva Med; 1976 Mar; 67(16):1067-9. PubMed ID: 1264382
    [No Abstract]   [Full Text] [Related]  

  • 11. [Respiratory function studies in patients with bronchopneumopathy treated with salbutamol].
    Spina G; Bonsignore C
    Minerva Med; 1976 Mar; 67(15):995-7. PubMed ID: 1264372
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
    Macha HN; Aurich R
    Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic action of salbutamol as compared with orciprenaline in patients with chronic obstructive bronchopneumopathy. Double-blind study].
    Vesco R; Sussi GW
    Minerva Med; 1976 Apr; 67(17):1155-9. PubMed ID: 772479
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a salbutamol-beclomethasone dipropionate combination in the treatment of chronic obstructive bronchopneumopathy].
    Greco N; Tosto L
    Clin Ter; 1984 Sep; 110(5):445-53. PubMed ID: 6238759
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the bronchospasmolytic action of fenoterol and iprafen].
    De Maria C; Casazza G
    Arch Monaldi; 1984; 39(3):223-5. PubMed ID: 6242134
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.